NCT00538681 2020-11-05Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + PlaceboEli Lilly and CompanyPhase 2 Terminated35 enrolled 14 charts